Search research articles
Contact Us
Filters
Showing results (21-30 of 294) with videos related to
Page
of 30
Sort By:
Current Opinion in Chemical Biology
|
October 7, 2014
Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase
Stephan Hailfinger, Georg Lenz, Margot Thome
Expert Review of Hematology
|
December 13, 2016
Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications
Jonas Lange, Georg Lenz, Birgit Burkhardt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2011
Pathogenesis of non-Hodgkin's lymphoma
Hendrik Nogai, Bernd Dörken, Georg Lenz
Blood
|
July 28, 2021
Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
Wendan Xu, Philipp Berning, Georg Lenz
Blood
|
April 28, 2018
Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas
Norbert Schmitz, Georg Lenz, Matthias Stelljes
Nature Communications
|
November 30, 2019
Dissection of gene expression datasets into clinically relevant interaction signatures via high-dimensional correlation maximization
Michael Grau, Georg Lenz, Peter Lenz
Acta Haematologica
|
October 6, 2021
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient
Marcel Kemper, Georg Lenz, Rolf Michael Mesters
Therapeutic Advances in Hematology
|
July 5, 2022
Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma
Fabian Frontzek, Imke Karsten, Norbert Schmitz, et al.
Expert Review of Hematology
|
October 5, 2019
Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphoma
Ramona Wullenkord, Birte Friedrichs, Tabea Erdmann, et al.
Leukemia & Lymphoma
|
September 7, 2010
Targeting the microenvironment
John Gribben, Andreas Rosenwald, Randy Gascoyne, et al.
Page
of 30
Search research articles
Search
Showing results (21-30 of 294) with videos related to
Sort By:
Page
of 30
Current Opinion in Chemical Biology
|
October 7, 2014
Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase
Stephan Hailfinger, Georg Lenz, Margot Thome
Expert Review of Hematology
|
December 13, 2016
Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications
Jonas Lange, Georg Lenz, Birgit Burkhardt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2011
Pathogenesis of non-Hodgkin's lymphoma
Hendrik Nogai, Bernd Dörken, Georg Lenz
Blood
|
July 28, 2021
Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
Wendan Xu, Philipp Berning, Georg Lenz
Blood
|
April 28, 2018
Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas
Norbert Schmitz, Georg Lenz, Matthias Stelljes
Nature Communications
|
November 30, 2019
Dissection of gene expression datasets into clinically relevant interaction signatures via high-dimensional correlation maximization
Michael Grau, Georg Lenz, Peter Lenz
Acta Haematologica
|
October 6, 2021
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient
Marcel Kemper, Georg Lenz, Rolf Michael Mesters
Therapeutic Advances in Hematology
|
July 5, 2022
Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma
Fabian Frontzek, Imke Karsten, Norbert Schmitz, et al.
Expert Review of Hematology
|
October 5, 2019
Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphoma
Ramona Wullenkord, Birte Friedrichs, Tabea Erdmann, et al.
Leukemia & Lymphoma
|
September 7, 2010
Targeting the microenvironment
John Gribben, Andreas Rosenwald, Randy Gascoyne, et al.
Page
of 30